Neutrophil-to-lymphocyte ratio predicts long-term survival in early triple negative breast cancer treated with neoadjuvant chemotherapy
NLR predicts long-term survival after NACT in TNBC and, as a readily and inexpensive information, should be further studied in current approaches of chemoimmunotherapy.
Authors
- VIVIANE ALVES DE OLIVEIRA
- Victor Rocha Pinheiro (ORCID: https://orcid.org/0000-0002-2761-901X)
- Laura Testa (ORCID: https://orcid.org/0000-0001-6080-7429)
- Romualdo Barroso‐Sousa (ORCID: https://orcid.org/0000-0002-1825-9876)
- Yumi Ricucci Shinkado (ORCID: https://orcid.org/0000-0003-1286-6904)
- Renata Colombo Bonadio (ORCID: https://orcid.org/0000-0001-5818-922X)
- Gabriel Berlingieri Polho (ORCID: https://orcid.org/0000-0003-2309-6175)
- Diana del Cisne Pineda Labanda
- Luciana Rodrigues Carvalho Barros (ORCID: https://orcid.org/0000-0002-8633-716X)
- Letícia Kimie Murazawa
Institutions
- Twitter (United States) (US)
- Instituto do Câncer do Estado de São Paulo (BR)
- D’Or Institute for Research and Education (BR)
- Sociedade de Anestesiologia do Rio Grande do Sul (BR)
Publication Details
- Journal
- ecancermedicalscience
- Published
- 2025-11-14
- DOI
- https://doi.org/10.3332/ecancer.2025.2034
- Citations
- 1
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.05